Intention of parents to have male children vaccinated with the human papillomavirus vaccine

Sexually Transmitted Infections

Volumn 84, Issue 4, 2008, Pages 318-323

  Ogilvie, Gina S ^a,c   Remple, V P ^a   Marra, F ^a,c   McNeil, S A ^b   Naus, M ^a,c   Pielak, K ^c   Ehlen, T ^a   Dobson, S ^a   Patrick, D M ^a,c   Money, D M ^a,d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^d British Columbia Women's Hospital   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CANADA; CHILD; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEALTH PRACTITIONER; HUMAN; IMMUNIZATION; KAPPA STATISTICS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PARENT; PREDICTION; PRIORITY JOURNAL; RISK; SEXUAL BEHAVIOR; VACCINATION; WART VIRUS;

ADOLESCENT; ADULT; AGED; ATTITUDE TO HEALTH; CANADA; CHILD; HUMANS; INTENTION; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PARENTS; SEX FACTORS;

EID: 49049094220     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2007.029389     Document Type: Article

References (32)

1. Partridge JM, Koutsky LA. Genital human papillomavirus infection in men. Lancet Infect Dis 2006;6:21-31.
2. Clifford G, Franceschi S, Diaz M, et al. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine 2006;24(Suppl 3):S26-34.
3. Aguilar LV, Lazcano-Ponce E, Vaccarella S, et al. Human papillomavirus in men: comparison of different genital sites. Sex Transm Infect 2006;82:31-3.
4. Giuliano AR. Human papillomavirus vaccination in males. Gynecol Oncol 2007;107 (2 Suppl):S24-6.
5. Block SL, Nolan T, Sattler C, et al. Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women. Pediatrics 2006;118:2135-45.
6. Reisinger KS, Block SL, Lazcano-Ponce E, et al. Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: a randomized controlled trial. Pediatr Infect Dis J 2007;26:201-9.
7. Garnett GP, Kim JJ, French K, et al. Chapter 21: Modelling the impact of HPV vaccines on cervical cancer and screening programmes. Vaccine 2006;24(Suppl 3):S178-86.
8. Hughes JP, Garnett GP, Koutsky L. The theoretical population-level impact of a prophylactic human papilloma virus vaccine. [see comment]. Epidemiology 2002;13:631-9.
9. Merck Frosst Canada Ltd. Gardasil Product Monograph. 2006. Kirkland, QC, Merck Frosst Canada Ltd.
10. Dobson S, Deeks S, Money DM. National Advisory Committee on Immunization statement on human papillomavirus vaccine. CCDH 2007;33:1-32.
11. Ogilvie GS, Remple VP, Marra F, et al. Parental Intention to have daughters receive the human papillomavirus vaccine. Can Med Assoc Journal 2007;177:1506-12.
12. Zimet GD. Improving adolescent health: Focus on HPV vaccine acceptance. J Adolesc Health 2005;37(6 suppl).
13. Hankins M, French D, Horne R. Statistical guidelines for studies of the theory of reasoned action and the theory of planned behaviour. Psychol Health 2000;15:151-61.
14. Dempsey AF, Zimet GD, Davis RL, et al. Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics 2006;117:1486-93.
15. Zimet GD. Improving adolescent health: focus on HPV vaccine acceptance. J Adolesc Health 2005;37(6 suppl).
16. Zimet GD, Liddon N, Rosenthal SL, et al. Chapter 24: Psychosocial aspects of vaccine acceptability. Vaccine 2006;24(Suppl 3):S201-9.
17. Zimet GD, Mays RM, Fortenberry JD. Vaccines against sexually transmitted infections: promise and problems of the magic bullets for prevention and control. Sex Transm Dis 2000;27:49-52.
18. Zimet GD, Perkins SM, Sturm LA, et al. Predictors of STI vaccine acceptability among parents and their adolescent children. J Adolesc Health 2005;37(3).
19. Lenselink CH, Gerrits MMJG, Melchers WJG, et al. Parental acceptance of human papillomavirus vaccines. Eur J Obstet Gynecol 2007: doi 10.1016/j.ejogrb.2007.02.12.
20. Lazcano-Ponce E, Rivera L, Arillo-Santillan E, et al. Acceptability of a human papillomavirus (HPV) trial vaccine among mothers of adolescents in Cuernavaca, Mexico. Arch Med Res 2001;32(3).
21. Noakes K, Yarwood J, Salisbury D. Parental response to the introduction of a vaccine against human papilloma virus. Human Vaccines 2006;2:243-8.
22. Olshen E, Woods ER, Austin SB, et al. Parental acceptance of the human papillomavirus vaccine. J Adolesc Health 2005;37(3).
23. Zimet GD, Mays RM, Fortenberry JD. Vaccines against sexually transmitted infections: promise and problems of the magic bullets for prevention and control. Sex Transm Dis 2000;27:49-52.
24. Dempsey AF, Zimet GD, Davis RL, et al. Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics 2006;117:1486-93.
25. Rosner B. Fundamentals of Biostatistics. 5th edn. Pacific Grave, California: 2000.
26. Colgrove J. The ethics and politics of compulsory HPV vaccination. N Engl J Med 2007;355:2389-91.
27. Marlow LAV, Waller J, Wardle J. Parental attitudes to pre-pubertal HPV vaccination. Vaccine 2007;25:1945-52.
28. Stanberry LR, Spruance SL, Cunningham AL, et al. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med 2002;347:1652-61.
29. Choi YH, Jit M, Gay N, Cox A, et al. Dynamic Models of HPV Transmission and the Impact of Vaccination Strategies on Cervical Cancer and Anogenital Warts in the UK. 24th International Papillomavirus Conference and Clinical Workshop 2007: Beijing, September 2007.
30. Ministry of Health GoBC. Immunization Coverage. 2006. Victoria, British Columbia, Government of British Columbia.
31. . Flaherty JM. Chapter 3: A better Canada. In: The budget plan 2007. Aspire to a strong, safer, better Canada. Ottawa: Department of Finance Canada: 2007 http://www.budget.gc.ca/2007/bp/bpc3e.html (accessed 12 October 2007).
32. Government of Ontario MoHaLTC. Human papilloma virus immunization program. Toronto: Government of Ontario, Ministry of Health and Long-Term Care; 2007. (http://www.health.gov.on.ca/english/media/news_releases/archives/nr_07/ aug/bg_20070802.html (accessed 12 October 2007).